The methylation status of CpG sites within the promoter/exon 1 regions of S100A6 and S100A2, which have previously been identified as being involved in their epigenetic regulation (Rehman et al, 2005), was established in a panel of nine medulloblastoma cell lines by bisulphite sequencing. The gene discussed is S100A6; the disease is medulloblastoma.